More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying

U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3 Seres Therapeutics The Trade: Seres Therapeutics, Inc. (NASDAQ: MCRB ) 10% owner Noubar Afeyan acquired a total of 8,738,243 shares at an average price of $3.15. To acquire these shares, it cost around $27.53 million. What’s Happening: Seres Therapeutics recently announced a $100 million registered direct offering of common stock. What Seres Therapeutics Does: Seres Therapeutics Inc is a ... Full story available on Benzinga.com